FR2181709B1 - - Google Patents

Info

Publication number
FR2181709B1
FR2181709B1 FR7304280A FR7304280A FR2181709B1 FR 2181709 B1 FR2181709 B1 FR 2181709B1 FR 7304280 A FR7304280 A FR 7304280A FR 7304280 A FR7304280 A FR 7304280A FR 2181709 B1 FR2181709 B1 FR 2181709B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7304280A
Other languages
French (fr)
Other versions
FR2181709A1 (xx
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2181709A1 publication Critical patent/FR2181709A1/fr
Application granted granted Critical
Publication of FR2181709B1 publication Critical patent/FR2181709B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FR7304280A 1972-02-07 1973-02-07 Expired FR2181709B1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22429272A 1972-02-07 1972-02-07

Publications (2)

Publication Number Publication Date
FR2181709A1 FR2181709A1 (xx) 1973-12-07
FR2181709B1 true FR2181709B1 (xx) 1975-10-10

Family

ID=22840026

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7304280A Expired FR2181709B1 (xx) 1972-02-07 1973-02-07

Country Status (15)

Country Link
JP (1) JPS4886880A (xx)
KR (1) KR780000029B1 (xx)
AR (1) AR195821A1 (xx)
AT (1) AT323744B (xx)
AU (1) AU5191873A (xx)
BE (1) BE795023A (xx)
DD (1) DD103644A5 (xx)
DE (1) DE2303838C2 (xx)
FR (1) FR2181709B1 (xx)
GB (2) GB1388213A (xx)
IE (1) IE37259B1 (xx)
IL (1) IL41463A0 (xx)
LU (1) LU66964A1 (xx)
NL (1) NL7301650A (xx)
ZA (1) ZA73137B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA738760B (en) * 1972-12-21 1974-08-28 Hoffmann La Roche Process for the manufacture of benzyl pyrimidines
GB1582245A (en) * 1976-06-09 1981-01-07 Wellcome Found Benzyl cyanoacetal derivatives and their conversion to pyrimidine derivatives
LU77268A1 (xx) * 1977-05-05 1979-01-18
CA1084498A (en) * 1977-05-05 1980-08-26 Alexander E. Wick Benzylpyrimidines and process for the preparation thereof
DE2910510A1 (de) * 1979-03-16 1980-09-25 Heumann Ludwig & Co Gmbh 2,4-diamino-5-benzylpyrimidine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1453056A (fr) * 1964-11-12 1966-04-15 Hoffmann La Roche Procédé pour la préparation de dérivés de pyrimidine
US3485840A (en) * 1964-11-12 1969-12-23 Hoffmann La Roche 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes
DE1620729A1 (de) * 1965-07-08 1970-08-20 Wellcome Found Verfahren zur Herstellung von substituierten Benzylpyrimidinen
US3715433A (en) * 1969-06-02 1973-02-06 Hoffmann La Roche Growth promotion in swine

Also Published As

Publication number Publication date
AT323744B (de) 1975-07-25
JPS4886880A (xx) 1973-11-15
GB1388213A (en) 1975-03-26
KR780000029B1 (en) 1978-03-10
BE795023A (fr) 1973-08-06
GB1388214A (en) 1975-03-26
DE2303838C2 (de) 1982-09-23
LU66964A1 (xx) 1974-09-25
AU5191873A (en) 1974-08-08
FR2181709A1 (xx) 1973-12-07
IE37259L (en) 1973-08-07
IL41463A0 (en) 1973-04-30
AR195821A1 (es) 1973-11-09
NL7301650A (xx) 1973-08-09
DD103644A5 (xx) 1974-02-05
IE37259B1 (en) 1977-06-08
ZA73137B (en) 1973-09-26
DE2303838A1 (de) 1973-08-16

Similar Documents

Publication Publication Date Title
FR2202664B3 (xx)
JPS4974967A (xx)
FR2181709B1 (xx)
JPS4942812A (xx)
FR2188056A1 (xx)
JPS4947374A (xx)
JPS4961851A (xx)
JPS4929790A (xx)
JPS48110717U (xx)
JPS4914291U (xx)
CH594325A5 (xx)
BE783740A (xx)
CH579003A5 (xx)
CH579257A5 (xx)
CH585708A5 (xx)
CH561352A5 (xx)
CH578464A5 (xx)
CH583527A5 (xx)
CH578036A5 (xx)
CH577134A5 (xx)
CH601129A5 (xx)
CH583217A5 (xx)
CH601233A5 (xx)
SE7010364L (xx)
CH586648A5 (xx)

Legal Events

Date Code Title Description
ST Notification of lapse